Literature DB >> 23098389

A cross-sectional study of clinical management, and provision of health services and their utilisation, by patients with Parkinson's disease in urban and regional Victoria.

Michal Lubomski1, R Louise Rushworth, Will Lee, Kelly Bertram, David R Williams.   

Abstract

Our objective was to evaluate and compare clinical management, utilisation of health services and quality of life (QoL) in patients with Parkinson's disease (PD) attending clinics in urban and regional Victoria. A cross-sectional survey was conducted on 210 patients with PD attending specialist neurological clinics in a regional area (Ballarat) (n=97), and an urban area (Melbourne) (n=113), Victoria. Demographic characteristics of patients with PD, QoL, patterns of disease and management and utilisation of medical and allied health services were analysed. Compared to patients with PD from urban clinics, patients in the regional clinic were significantly older and were diagnosed at a later age with a shorter duration of treatment (all p<0.05). Despite no significant difference in disease severity (measured by Unified Parkinson's Disease Rating Scale scores) between the groups, patients in the urban clinic reported a lower QoL (p=0.003). Patients in the regional clinic were more satisfied with their treatment, despite seeing their medical specialist less frequently (p<0.001) and having a higher rate of early misdiagnosis (p=0.015). Patients from regional clinics reported a poorer understanding of their illness than patients in the urban clinic (p=0.049). Half of all respondents were interested in using telemedicine services. Two-thirds (71%) of all patients used allied health services, with patients in the urban clinic utilising more and desiring greater access to these services (p<0.05). In conclusion, we found significant differences in the presentation, management and use of health services between patients accessing regional and urban PD clinics in Victoria. Telemedicine may be an effective, and even desirable, method for facilitating improved diagnosis and referral for appropriate therapies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23098389     DOI: 10.1016/j.jocn.2012.05.015

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Michal Lubomski; Ryan L Davis; Carolyn M Sue
Journal:  J Neurol       Date:  2020-01-27       Impact factor: 4.849

2.  The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies.

Authors:  Michal Lubomski; Xiangnan Xu; Andrew J Holmes; Samuel Muller; Jean Y H Yang; Ryan L Davis; Carolyn M Sue
Journal:  Front Aging Neurosci       Date:  2022-05-17       Impact factor: 5.702

3.  Nutritional Intake and Gut Microbiome Composition Predict Parkinson's Disease.

Authors:  Michal Lubomski; Xiangnan Xu; Andrew J Holmes; Samuel Muller; Jean Y H Yang; Ryan L Davis; Carolyn M Sue
Journal:  Front Aging Neurosci       Date:  2022-05-11       Impact factor: 5.702

Review 4.  Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.

Authors:  Claudio Soto; Sandra Pritzkow
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

5.  A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson's Disease.

Authors:  Satoko Sekimoto; Genko Oyama; Taku Hatano; Fuyuko Sasaki; Ryota Nakamura; Takayuki Jo; Yasushi Shimo; Nobutaka Hattori
Journal:  Parkinsons Dis       Date:  2019-01-06

6.  Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE-PD observational study.

Authors:  Alfonso Fasano; Victor S C Fung; Klaus Seppi; Zvezdan Pirtosek; Annamária Takáts; Ali Alobaidi; Koray Onuk; Lars Bergmann; Juan Carlos Parra; Bulent Elibol
Journal:  Acta Neurol Scand       Date:  2022-05-24       Impact factor: 3.915

Review 7.  Barriers to Accessing Healthcare Services for People with Parkinson's Disease: A Scoping Review.

Authors:  Muhammed Shahriar Zaman; Setareh Ghahari; Mary Ann McColl
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.